Thailand In Vitro Fertilisation (IVF) Service Market Analysis Sample Report

1. A sample report on Thailand IVF Service Market Includes Market Size, Market Segmented by Types and Key Competitors (Data forecasts from 2022 – 2030F) www.insights10.com

2. This report presents a strategic analysis of the Thailand In Vitro Fertilisation (IVF) Service Market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, types of clinical diagnostics, point- of-care testing, main players, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about the Thailand In Vitro Fertilisation (IVF) Service Market, and offers unmatched value, accuracy, and expert insights

3. Report Scope Report Attribute Details Number of Pages 70-80 Base Year for Estimation 2022 Forecast Period 2023-2030 Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends, Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape, Reimbursement Scenario Report Coverage Quantitative Units Revenue in USD Million/Billion (Mn/Bn) Research Approach Secondary Research (60%), Primary Research (40%) Click on the icon to know the detailed methodology 3 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

4. Table of Content CONTENT PG. NO. 12-25 1. In Vitro Fertilisation (IVF) Service Overview 1.1. Overview 1.2. Thailand Overview 1.3. Economic Overview: Thailand 1.4. In Vitro Fertilisation (IVF) Service Market in Thailand 1.5. Healthcare Services Market in Thailand 1.6. Healthcare Scenario in Thailand 1.7. Health Insurance Coverage: Thailand 1.8. Budget of the Government for Public Insurance 1.9. Mergers and Acquisitions 26-32 2. Market Size and Forecasting 2.1 Market size and forecasts (Excel and Methodology) 4 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

5. CONTENT PG. NO. 2.2. Market Segmentation 2.2.1. By Cycle Type 2.2.2. By Type of Treatment 2.2.3. By Cause of Infertility 2.2.4. By End User 33-37 3. Market Dynamics 3.1. Market Growth Drivers 3.1.1. Thailand In Vitro Fertilisation (IVF) Service Market Driver 1 3.1.2. Thailand In Vitro Fertilisation (IVF) Service Market Driver 2 3.1.3. Thailand In Vitro Fertilisation (IVF) Service Market Driver 3 3.2. Market Restraints 3.2.1. Thailand In Vitro Fertilisation (IVF) Service Market Restraint 1 5 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

6. Table of Content CONTENT PG. NO. 3.2.3. Thailand In Vitro Fertilisation (IVF) Service Market Restraint 2 38-48 4. Competitive Landscape 4.1. Major Market Share 4.2. Key Company Profile 4.2.1. Piyavate Hospital 4.2.1.1. Overview 4.2.1.2. Product Applications & Services 4.2.1.3. Recent Developments 4.2.1.4. Partnerships Ecosystem 4.2.1.5. Financials (Based on Availability) 4.2.2. First fertility 4.2.2.1. Overview 6 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

7. Table of Content CONTENT PG. NO. 4.2.2.2. Product Applications & Services 4.2.2.3. Recent Developments 4.2.2.4. Partnerships Ecosystem 4.2.2.5. Financials (Based on Availability) 4.2.3. Bumrungrad International Hospital 4.2.3.1. Overview 4.2.3.2. Product Applications & Services 4.2.3.3. Recent Developments 4.2.3.4. Partnerships Ecosystem 4.2.3.5. Financials (Based on Availability) 4.2.4. Samitivej Hospital 4.2.4.1. Overview 7 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

8. Table of Content CONTENT PG. NO. 4.2.4.2. Product Applications & Services 4.2.4.3. Recent Developments 4.2.4.4. Partnerships Ecosystem 4.2.4.5. Financials (Based on Availability) 4.2.5. Bangkok IVF Center 4.2.5.1. Overview 4.2.5.2. Product Applications & Services 4.2.5.3. Recent Developments 4.2.5.4. Partnerships Ecosystem 4.2.5.5. Financials (Based on Availability) 4.2.6. Vejthani Hospital 4.2.6.1. Overview 8 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

9. Table of Content CONTENT PG. NO. 4.2.6.2. Product Applications & Services 4.2.6.3. Recent Developments 4.2.6.4. Partnerships Ecosystem 4.2.6.5. Financials (Based on Availability) 4.2.7. Superior A.R.T. 4.2.7.1. Overview 4.2.7.2. Product Applications & Services 4.2.7.3. Recent Developments 4.2.7.4. Partnerships Ecosystem 4.2.7.5. Financials (Based on Availability) 4.2.8. Siriraj Hospital 4.2.8.1. Overview 9 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

10. Table of Content CONTENT PG. NO. 4.2.8.2. Product Applications & Services 4.2.8.3. Recent Developments 4.2.8.4. Partnerships Ecosystem 4.2.8.5. Financials (Based on Availability) 4.2.9. Vibhavadi Hospital 4.2.9.1. Overview 4.2.9.2. Product Applications & Services 4.2.9.3. Recent Developments 4.2.9.4. Partnerships Ecosystem 4.2.9.5. Financials (Based on Availability) 4.2.10. Pattaya IVF Center 4.2.10.1. Overview 10 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

11. Table of Content CONTENT PG. NO. 4.2.10.2. Product Applications & Services 4.2.10.3. Recent Developments 4.2.10.4. Partnerships Ecosystem 4.2.10.5. Financials (Based on Availability) 49-56 5. Reimbursement Scenario 5.1. Reimbursement Regulation in Thailand 5.2. Reimbursement Process for IVF in Thailand 5.3. Reimbursement Process for IFV Services in Thailand 5.4 Reimbursement Process – Medicare 5.5 Reimbursement Process - Medicaid 57-62 6. Methodology & Scope 11 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

12. Thailand In Vitro Fertilisation (IVF) Service Market Analysis 1. In Vitro Fertilisation (IVF) Service Overview

13. 1.1 Overview of In Vitro Fertilisation (IVF) Service in the World Prevalence of InfertilityGlobally Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ 48 Mn couples and 186 Mn individuals worldwide live 1 in 6 people globally affected by infertility In this section you will get an understanding of the topic, which includes the prevalence of the disease, the application of medical devices, new technology, and other details related to the topic ▪ 17.5% of the adult population affected by infertility 2.5% to 12% male infertility range globally 6.5% Lifetime prevalence was in low- and middle-income countries. 17.8% Lifetime prevalence was in high- income countries In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Over 8 Mn IVF children have been born Over 2.5 Mn cycles are being performed every year, resulting in over 500,000 deliveries annually 13 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

14. 1.1 Overview of In Vitro Fertilisation (IVF) Service Market in the World (continued) Europe ~Revenue to reach $XX Bn by 2027 Asia -Fastest CAGR North America ~ Market Size of $XX Bn Africa Thailand Market ~$XX Mn Market ~Market Size of $XX Bn 14 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

15. 1.2 Thailand Overview Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, healthcare expenditure and other details related to the topic ▪ 71.6 Mn Is the population of Thailand, in 2021 50^ Bn Is the Gross Domestic Product (GDP) in Thailand in 2021 In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 41 Is the median age in Thailand, in 2022 $7,066.19 per capita was the amount of national health expenditures in 2021 15 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

16. 1.3 Economic Overview: Thailand Population of Thailand, (2020-2030) GDP of Thailand, (2020-2030) XX XX XX XX 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F Population Split (2023) In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, healthcare expenditure and other details related to the topic ▪ By Gender By Age Group In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ 0-14 15-24 25-54 Male 49% Female 51% Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 55-64 65+ Illustrative Illustrative 16 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

17. 1.4 Overview of In Vitro Fertilisation (IVF) Service in Thailand Success rate of IVF service in Thailand Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ 99% IVF with Donor Egg 75% Self IVF Program 90% IVF with ICSI 50% IVF with medical conditions 82% Laser assisted hatching program In this section you will get an understanding of the topic, which includes the prevalence of the disease, the application of medical devices, new technology, and other details related to the topic in Thailand 85% IVF with PGD/PGT ▪ The current fertility rate for Thailand in 2023 is 1.461 births per woman, a 1.02% decline from 2022. The fertility rate for Thailand in 2022 was 1.476 births per woman, a 1.01% decline from 2021. The fertility rate for Thailand in 2021 was 1.491 births per woman, a 0.93% decline from 2020. The fertility rate for Thailand in 2020 was 1.505 births per woman, a 0.99% decline from 2019. ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ ▪ ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ ▪ 17 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

18. 1.5 Healthcare Services in Thailand Thailand Pharmaceutical Market Forecast, 2022-2030 (in $Bn) xx xx xx xx xx xx xx xx xx 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In this section you will get an understanding of the overall Healthcare Services market in Thailand, which includes the market size, current trends and other details related to the topic ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Illustrative Illustrative 18 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

19. 1.6 Healthcare Scenario in Thailand Cancer Drug Development Process: The process of developing a cancer drug is complex and involves many stages, from preclinical research to clinical trials to regulatory approval. Here is a simplified diagram of the cancer drug development process: Preclinical Research: Researchers identify potential drug candidates and test them in the lab Phase 1 Clinical Trials: Small studies are conducted to test the safety and dosage of the drug in humans Phase 2 Clinical Trials: Larger studies are conducted to test the effectiveness of the drug in treating cancer Phase 3 Clinical Trials: Even larger studies are conducted to compare the new drug to standard treatments and evaluate its safety and effectiveness Regulatory Approval: The drug is reviewed by regulatory agencies such as the FDA and approved for use in the US market o o o o o FDA has developed several approaches to making drugs available as quickly as possible, while still ensuring their safety and effectiveness. Here are four of these approaches: Fast track is a process designed to facilitate the development, and expedite the review of drugs to treat serious conditions and fill an unmet medical need ▪ Fast Track A process designed to expedite the development and review of drugs which may demonstrate substantial improvement over available therapy Breakthrough Therapy ▪ These regulations allowed drugs for serious conditions that filled an unmet medical need to be approved based on a surrogate endpoint Accelerated Approval ▪ Priority Review A Priority Review designation means FDA’s goal is to take action on an application within 6 months ▪ Illustrative Illustrative This is the budget of the US govt. for public insurance, you will get Thailand govt. for public insurance in Final Report 19 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

20. 1.6 Healthcare Scenario: IVF Patient Journey Ovarian Stimulation Treatment Planning Initial Consultation Fertility Assessment The patient begins by scheduling an initial consultation with a fertility specialist or reproductive endocrinologist at a reputable IVF clinic in Thailand. During this consultation, the doctor will review the patient's medical history, perform necessary examinations, and discuss potential treatment options. Based on the fertility assessment results and the patient's individual circumstances, the doctor will develop a personalized treatment plan. This plan may include medication protocols, stimulation protocols, and the recommended number of IVF cycles. The patient begins ovarian stimulation, which involves taking fertility medications to stimulate the ovaries and promote the growth of multiple follicles. Regular monitoring through ultrasound scans and blood tests is conducted to assess follicular development. The patient undergoes a series of fertility assessments, including blood tests, hormonal evaluations, and ultrasound scans. These tests help the doctor assess the patient's ovarian reserve, hormone levels, and overall reproductive health. Egg Retrieval: Fertilization Pregnancy Test Embryo Transfer Luteal Phase Support Approximately two weeks after the embryo transfer, a pregnancy test is conducted to determine if the treatment was successful. If the test is positive, the patient will continue with regular follow-up appointments and monitoring to ensure a healthy pregnancy. Once the follicles reach the appropriate size, the patient undergoes an egg retrieval procedure. This is typically performed under sedation or anesthesia, and a needle is used to retrieve the mature eggs from the ovaries. After a few days of development, the embryos are transferred into the uterus. The number of embryos transferred is determined based on factors such as the patient's age, embryo quality, and the doctor's recommendation. The retrieved eggs are then fertilized with sperm in the laboratory through either conventional IVF or Intracytoplasmic Sperm Injection (ICSI) technique. The embryos are closely monitored for development. Following the embryo transfer, the patient may receive luteal phase support in the form of hormone medications to assist with implantation and support early pregnancy. 20 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

21. 1.7 Health Insurance Coverage % of People by Type of Health Insurance Coverage (2021) Number of People By Health Insurance Coverage Coverage Type 2020 2021 Change % 8.3 Uninsured Total 327,521 328,074 91.7 With health insurance Any health plan 299,230 300,887 0.4 Any private plan 217,896 216,366 –0.6 66.0 Any private plan Employment-based 178,737 178,285 –0.2 54.3 Employment-based Direct-purchase 33,869 33,555 –0.1 10.2 Direct-purchase Marketplace coverage 10,924 11,389 0.1 3.5 Marketplace TRICARE 9,165 8,299 –0.3 2.5 TRICARE Any public plan 112,925 117,095 1.2 Medicare 58,541 60,226 0.5 35.7 Any public plan 18.4 Medicare Medicaid 58,778 61,940 0.9 18.9 Medicaid VA and CHAMPVA 2,967 3,151 0.1 1.0 VA and CHAMPVA Uninsured 28,291 27,187 –0.4 In 2021, most people (91.7%) had health insurance coverage at some point during 2021 and 8.3 % of people were uninsured for the entire calendar year ▪ More people had private health insurance (66%) than public coverage (35.7%) ▪ Employer-based insurance was the most common subtype of health insurance in the civilian, noninstitutionalized population (54.3%), followed by Medicaid (18.9%), Medicare (18.4%), direct-purchase insurance (10.2%), TRICARE (2.5%), and VA and CHAMPVA health care (1%) ▪ Illustrative Illustrative This is the US Health Insurance coverage, you will get Thailand Health Insurance coverage in Final Report 21 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

22. 1.8 Budget of Thailand Government for Public Insurance Proposed Budget By Category 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31 Outlays $769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633 Medicare In Billions Of Dollars $458 $521 $571 $582 $616 $645 $674 $698 $734 $768 $801 $837 $6,926 Medicaid 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7% Medicare As % Of GDP 2.2% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.5% 2.5% 2.5% 2.5% 2.4% Medicaid National Health Expenditures (NHE) grew 2.7% to $4.3 trillion in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP) ▪ Medicare spending grew 8.4% to $900.8 billion in 2021, or 21% of total NHE ▪ Medicaid spending grew 9.2% to $734.0 billion in 2021, or 17% of total NHE ▪ Private health insurance spending grew 5.8% to $1,211.4 billion in 2021, or 28% of total NHE ▪ Out of pocket spending grew 10.4% to $433.2 billion in 2021, or 10% of total NHE ▪ Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 billion, or 14% oftotal NHE ▪ Hospital expenditures grew 4.4% to $1,323.9 billion in 2021, slower than the 6.2% growth in 2020 ▪ Physician and clinical services expenditures grew 5.6% to $864.6 billion in 2021, slower growth than the 6.6% in 2020 ▪ Prescription drug spending increased 7.8% to $378.0 billion in 2021, faster than the 3.7% growth in 2020 ▪ Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7% ▪ Illustrative Illustrative 22 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

23. 1.9 Mergers and Acquisitions RCM M&A Deal Value Trend ($Bn) RCM M&A Deal Volume Trend $16.7 112 110 107 107 89 82 $11.7 $10.5 $7.7 $6.8 $6.0 1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022 1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022 Buyer Composition: Strategic Vs Financial (2020) Buyer Type by Deal Size ($Mn) 39% 41% 41% 42% 58% 59% 59% 61% Strategic Buyers Financial Buyers $0- $25 $25-$50 $50-$100 $100+ 57% of the total deal volume are done by strategic buyers and the rest 43% are done by financial buyers in 2020 Illustrative Illustrative 23 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

24. 1.9 In Vitro Fertilization Market News (continued) Latest Deals In Thailand Amount / Duration Company Name Year Key Pointers Oma Fertility emerges from stealth and introduces a first-of-its-kind network of fertility clinics, offering families science-forward, AI-informed fertility treatments, paving the way for a new standard in IVF success rates. ▪ - June 2022 Boston IVF, one of the world’s most experienced fertility providers, signed a partnership with the Delaware Institute for Reproductive Medicine (DIRM). The unique partnership aims to deliver world-class fertility treatments and care locally through innovative treatments like in vitro fertilization (IVF), preimplantation genetic testing, male infertility, and others. ▪ - January 2022 24 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

25. 1.9 In Vitro Fertilization Market News (continued) Latest Deals In Thailand Amount / Duration Company Name Year Key Pointers - - Illustrative Illustrative 25 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

26. Thailand In Vitro Fertilisation (IVF) Service Market Analysis 2. Market Size and Forecasting

27. 2.1 Market size and forecasts (Excel and Methodology) Click on the icon to know the methodology and assumption Thailand IVF Market Forecast, 2022-2030 (in $Bn) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ XX XX In this section you will get an understanding of the overall Healthcare Insurance market in Malaysia, which includes the market size, current trends and other details related to the topic ▪ 2022 2023F 2024F 2025F 2026F 2025 2027F 2026 2028F 2027 2029F 2030F 2023 2024 2028 2029 2030 In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Major Markets Patient (Mn) 2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12 Thailand Patient Size (Bn) 0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73 Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative Illustrative ▪ % of US Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45% Global Market Size (Bn $) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937 Thailand Market Size (Bn $) 61 74 84 87 91 95 99 106 27 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

28. 2.2 Snapshot of IVF Service Market Segmentation By Cycle Type: By Type of Treatment: By Cause of Infertility: By End User Fresh In Vitro Fertilization Cycles Female factor infertility Conventional IVF Fertility Clinics Thawed In Vitro Fertilization Cycles ICSI Male factor infertility Hospitals Donor Egg In Vitro Fertilization Cycles Unexplained infertility FET Surgical Centers Donor egg or sperm IVF Clinical Research and Institute PGT Natural cycle IVF. In this section you will get an understanding of the segmentations which will cover the Thailand IVF Service Market In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ ▪ 28 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

29. 2.2.1 Market Segmentation: By Cycle Type Thailand Cancer Market Share, By Cycle Type (2022) Fresh In Vitro Fertilization Cycles market in Thailand is a significant component of the overall IVF Service treatment market ▪ Donor Egg In Vitro Fertilization Cycles It has the maximum market share in Thailand cancer market with approximately xx% ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Fresh In Vitro Fertilization Cycles Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Thawed In Vitro Fertilization Cycles Illustrative Illustrative 29 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

30. 2.2.2 Market Segmentation: By Type of Treatment Thailand Cancer Market Share, By Type of Treatment (2022) By Type of treatment market in Thailand, conventional IVF is a significant component of the overall IVF service market ▪ Natural cycle IVF. PGT Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Conventional IVF Donor egg or sperm IVF In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ FET ICSI Illustrative Illustrative 30 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

31. 2.2.3 Market Segmentation: By Cause of Infertility Thailand Cancer Market Share, By Cause of Infertility (2022) Female factor infertility have the maximum market share in Thailand IVF service market with approximately xx% ▪ Unexplained infertility Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Female factor infertility Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Male factor infertility Illustrative Illustrative 31 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

32. 2.2.4 Market Segmentation: By End User UAE Nutritional Supplements Market Share, By End User (2022) Fertility clinics have the maximum market share in Thailand IVF service market with approximately xx% ▪ Clinical Research and Institute Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Fertility Clinics In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Surgical Centers Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Hospitals Illustrative Illustrative 32 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

33. Thailand In Vitro Fertilisation (IVF) Service Market Analysis 3. Market Dynamics

34. 3.1 Market growth drivers 3.1.1 Incidence of cancer is increasing in Thailand, with more than 1.8 Mn new cancer cases expected to be diagnosed in 2023 Incidence of cancer is increasing in Thailand, with more than 1.8 Mn new cancer cases expected to be diagnosed in 2023 ▪ Incidence of Cancer in Thailand This is driving the demand for cancer treatments and creating opportunities for growth in the cancer market ▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 2010 2022 2030 Illustrative Illustrative These are the drivers and restraints of US cancer market you will get Thailand IVF services market drivers in Final Report 34 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

35. 3.1 Market growth drivers (continued) 3.1.2 Death rate from cancer in Thailand has declined by 31% from 1992 to 2022, largely due to advances in technology and treatment options Top countries that are leveraging technology in their fight against cancer Thailand has a long history of investing in cancer research and treatment, and as a result, has become a world leader in the field ▪ Norway IT has a robust healthcare infrastructure, including world- renowned research institutions, hospitals, and clinics, that are dedicated to cancer treatment and research ▪ Austria Denmark Belgium Spain Italy One of the key factors that has allowed Thailand to stay ahead in the field of cancer research and treatment is the high level of investment in cancer-related research ▪ Netherlands Sweden Singapore Switzerland Israel In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Australia Canada France Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ United Kingdom China South Korea Germany Japan United States Illustrative Illustrative These are the drivers and restraints of US cancer market you will get Thailand IVF services market drivers in Final Report 35 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

36. 3.1 Market growth drivers (continued) 3.1.3 In 2021, the National Cancer Institute (NCI) received $6.4 Bn in funding from Thailand federal government to support cancer research and training programs Fundings from government and other organizations Thailand government provides significant support and funding for cancer research and treatment, which is driving innovation and growth in the cancer market ▪ Source Year Fund ($) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ National Cancer Institute (NCI) 2021 $ 6.4 Bn In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Centers for Disease Control and Prevention (CDC) 2021 $ 501 Mn Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ American Cancer Society (ACS) 2020 $ 150 Mn Susan G. Komen 2020 $ 98 Mn Illustrative Illustrative These are the drivers and restraints of US cancer market you will get Thailand IVF services market drivers in Final Report 36 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

37. 3.2 Market restraints 3.2.1 In 2020, the average cost of a new cancer drug was over $150,000 per year 3.2.2 Average cost of developing a new cancer drug that is ultimately approved by the FDA is over $2.6 Bn 3.2.3 Demand for cancer care is expected to increase by 42% by 2025, while the supply of oncologists is only expected to increase by 28% Cancer treatments can be very expensive and can lead to financial burden for patients and healthcare systems Cost of cancer treatment varies depending on the type of cancer, stage of cancer, and treatment options Some common cancer treatments, such as chemotherapy and radiation therapy, can cost tens of thousands of dollars Regulatory requirements for cancer treatments can be very stringent, which can slow down the approval process and limit access to new treatments This can be a lengthy and costly process, which can delay the availability of new treatments for patients There is a shortage of oncologists in Thailand, which can limit access to cancer treatments and create barriers to growth in the cancer market Oncologists are physicians who specialize in the diagnosis and treatment of cancer However, the supply of oncologists is not keeping pace with the demand ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ Our analysis will thoroughly investigate the key restraints that may significantly impact business operations and growth. Illustrative Illustrative These are the drivers and restraints of US cancer market you will get Thailand IVF services market drivers in Final Report 37 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

38. Thailand In Vitro Fertilisation (IVF) Service Market Analysis 4. Competitive Landscape

39. 4.1 Major Market Share Thailand IVF service market is a highly competitive space, with many companies developing and marketing cancer treatments ▪ Revenue of Major players in Thailand IVF Service Market ($ Mn) Company10 Company 9 Some of the top companies in Thailand IVF service market based on revenue and market share include ▪ Company 8 Company 7 In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Company 6 Company 5 Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Company 4 Company 3 Company 2 Company 1 XX Illustrative Illustrative 39 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

40. 4.2 Key Company Profile Key Note: Here is the list of top 10 companies which will cover in the final report ▪ 1 Piyavate Hospital Each company will have slides for ▪ 2 First fertility Overview Key details Offerings Name of products Recent activities/ Press Coverage Distribution and Vendor Partners Mergers, Acquisitions and Collaboration Financials If there are specific companies that you would like to be included in the report, please let us know via email In order to obtain access to all of the information that you are seeking, you will need to purchase the final report o Bumrungrad International Hospital 3 o o 4 Samitivej Hospital o o 5 Bangkok IVF Center o o 6 Vejthani Hospital o 7 Superior A.R.T. ▪ 8 Siriraj Hospital ▪ 9 Vibhavadi Hospital 10 Pattaya IVF Center Illustrative Illustrative 40 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

41. 4.2.1 Piyavate Hospital Key Executives Founded in: 1993 ▪ Piyavate Hospital offers a wide range of medical specialties and services ▪ These include general medicine, surgery, obstetrics and gynecology, pediatrics, orthopedics, cardiology, dermatology, neurology, urology, ophthalmology, and more ▪ They also provide specialized services such as fertility treatments, including IVF (In Vitro Fertilization) and IUI (Intrauterine Insemination) Dr. Witit Attavejkul: Managing Director and CEO ➢ HQ: Bangkok, Thailand Dr. Chareoung Chandrakamol: President ➢ Type: Private Paisarn Nitiprapa: Chief Financial Officer (CFO) ➢ Revenue: $73.2 Mn Website:. https://piyavate.com/ Benjamin Tan: Assistant to CEO and Director Of Marketing ➢ IVF services provided by Piyavate Hospital Recent Activity / Press Coverage ▪ September 21, 2022: Creativity Award is presented to hospitals that demonstrate ongoing creativity and innovative approaches in various ways to maximize benefits for their customers. Which recognizes hospitals that maintain excellent service standards IVF (In Vitro Fertilization) Donor Egg IVF ICSI (Intracytoplasmic Sperm Injection): Surrogacy ▪ 2022: Piyavate Hospital has made significant strides in improving the pregnancy success rate among its clients. In 2022, they achieved an impressive overall success rate of 63.96% ▪ Notably, clients aged under 29 years experienced an exceptional success rate of 85.71%, while those in the 30-39 age group achieved a success rate of 65.6%. For clients aged between 40-49 years, the success rate stood at 48.65% Blastocyst Culture and Transfer Fertility preservation Preimplantation Genetic Testing (PGT) Frozen Embryo Transfer (FET) 41 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

42. 4.2.1 Piyavate Hospital (continued) Latest Deals - Mergers and Acquisitions Amount / Duration Company Name Type Year Key Pointers Piyavate Hospital’ joins hands with ‘PTT-CP Group’ to open a 350-bed field hospital to support mid- to critical covid patients ▪ August, 2021 Collabration - Piyavate Hospital and PTT-CP Group Illustrative Illustrative 42 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

43. 4.2.1 Piyavate Hospital (continued) Revenues ($Bn), 2020-2030 According to Piyavate Hospital 2020 financial report, the hospital had total revenue of XX Mn in 2022 ▪ XX Hospital’s IVF service division generated of XX Mn in 2022. ▪ XX XX Revenue generated by Piyavate Hospital in 2022 reflects the hospital’s continued growth and success in the healthcare industry ▪ 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Breakdown of Net Revenue by Segment, 2022 1 2 3 4 Illustrative Illustrative 43 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

44. 4.2.2 Company 2 Solutions offered by Company Founded in: HQ: Type: Revenue: Website: Drugs for Cancer Recent Activity / Press Coverage Drugs Indications Illustrative Illustrative 44 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

45. 4.2.2 Company 2 (continued) Partnerships Ecosystem Major Distribution Partners Major Vendor Partners Illustrative Illustrative 45 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

46. 4.2.2 Company 2 (continued) Latest Deals - Mergers and Acquisitions Amount / Duration Company Name Type Year Key Pointers Illustrative Illustrative 46 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

47. 4.2.2 Company 2 (continued) Revenues ($Bn), 2020-2030 Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ xx xx xx In this section you will the understating of financial overview of the company, which includes revenue forecasting, segment revenue and other key details as per availability ▪ 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Breakdown of Net Revenue by Segment, 2022 Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 1 2 3 4 Illustrative Illustrative 47 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

48. Thailand In Vitro Fertilisation (IVF) Service Market Analysis 5. Reimbursement Scenario

49. 5.1 Reimbursement Regulation in Thailand Public and Private health insurance coverage in Thailand In Thailand, the healthcare system consists of both public and private sectors. The reimbursement regulations in Thailand depends on whether the services are provided through the public universal healthcare scheme or private health insurance. Here are some key aspects of healthcare reimbursement regulations in Thailand: Public Universal Healthcare Scheme (UC Scheme): Under the UC Scheme, which is known as the "30-Baht Scheme," Thai citizens are eligible for basic healthcare services at public healthcare facilities. The reimbursement is primarily handled by the National Health Security Office (NHSO). Patients are required to pay a nominal fee of 30 Baht per visit, and the rest of the costs are reimbursed by the scheme Social Security Scheme: Employees and workers in the formal sector contribute to the Social Security Scheme, which provides health insurance coverage. Reimbursement for healthcare services is managed by the Social Security Office (SSO). The scheme covers both inpatient and outpatient services Civil Servant Medical Benefit Scheme: Civil servants and their dependents are covered under the Civil Servant Medical Benefit Scheme. The reimbursement for healthcare services is administered by the Comptroller General's Department (CGD). The scheme provides coverage for both inpatient and outpatient services, with specific reimbursement rates based on the type of service ▪ o Uninsured 19% Public Insurance 36% ▪ o ▪ Private Health Insurance 45% o Health Insurance Coverage, 2022 49 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential

50. 5.1 Reimbursement Regulation (continued) Private Health Insurance: Private health insurance plays a significant role in Thailand's healthcare system. The reimbursement regulations for private health insurance plans may vary depending on the specific insurance provider and policy. Private insurers typically have their own coverage limits, reimbursement rates, and eligibility criteria Uninsured Population: Despite efforts to achieve universal health coverage, there is still a portion of the Thai population that remains uninsured. This include individuals who are not eligible for public health insurance schemes or have not obtained private health insurance coverage ▪ o ▪ o 50 A Sample Report on Thailand In Vitro Fertilisation (IVF) Service Market Analysis I Confidential